| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/09/2009 | CN101597327A O-type foot and mouth disease virus antigen epitope molecular mimic peptide and application thereof |
| 12/09/2009 | CN101596315A Application of ZNF300 immune body of people for preparing medicines for treating and preventing leukemia |
| 12/09/2009 | CN101596314A Mixed-fat polypeptide vaccine for preventing and treating viral hepatitis C |
| 12/09/2009 | CN101596313A Method for preparing oligosaccharide molecular vaccine |
| 12/09/2009 | CN101596312A Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 12/09/2009 | CN100567987C T cell bacterin and preparation method thereof |
| 12/09/2009 | CN100567501C Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 12/09/2009 | CN100567496C Immunization of fish with plant-expressed recombinant proteins |
| 12/09/2009 | CN100567488C Enhancement of virus-mediated DNA transfer |
| 12/09/2009 | CN100567323C Preparation of testis specific protein 50 monoclonal antibody and polyclonal antibody and use |
| 12/09/2009 | CN100566753C A hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/09/2009 | CN100566752C Fishes infectious spleen and kidney necrosis virus gene engineering vaccine and preparation method thereof |
| 12/09/2009 | CN100566751C Method for preparing poultry cholera microcapsule vaccine |
| 12/09/2009 | CN100566750C An auto T cell vaccine against T lymphocytoma and preparation method thereof |
| 12/08/2009 | US7629453 NF-κB activating gene |
| 12/08/2009 | US7629440 Comprises fusion proteins isolated from influenza virus hemagglutinin and colony stimulating factor |
| 12/08/2009 | US7629327 Chlamydia 60 Kda CRMP antigens and vaccine uses |
| 12/08/2009 | US7629312 Method of treatment of tendonitis by administration of streptolysin O |
| 12/08/2009 | US7629311 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers |
| 12/08/2009 | US7629149 Polynucleotide encoding an IL-28A polypepide |
| 12/08/2009 | US7629148 Polynucleotide encoding an IL-28B polypeptide |
| 12/08/2009 | US7629132 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, apoptosis and autoimmune diseases |
| 12/08/2009 | US7629117 Using immunoglobulin specific to membrane attack complex (SC5b-9) as diagnostic tool in detection of dengue viral infection |
| 12/08/2009 | US7629003 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 12/08/2009 | US7628996 Sterile immunogenic non-tumorigenic tumor cell compositions and methods |
| 12/08/2009 | US7628995 Outer membrane vesicles and uses thereof |
| 12/08/2009 | US7628994 S. epidermidis antigens |
| 12/08/2009 | US7628993 Compositions and methods for vaccinating against HSV-2 |
| 12/08/2009 | US7628992 Modification of clostridial toxins for use as transport proteins |
| 12/08/2009 | US7628991 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies |
| 12/08/2009 | US7628990 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 12/08/2009 | US7628989 Methods of inducing an immune response |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |
| 12/08/2009 | US7628987 Vectors derived from antibodies for transferring substances into cells |
| 12/08/2009 | US7628986 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 12/08/2009 | US7628982 Boosting an immune response in an animal; vaccine containing B. subtilis spores, in the presence or absence of an antigen |
| 12/08/2009 | US7628980 Inducing long-term protection against foreign antigens and tumor antigens by administering a type I interferon or a FMS-like tyrosine kinase 3 (Flt-3), optionally along with an attenuated virus; increasing of the number of dendritic cells |
| 12/08/2009 | CA2461117C Botulinus toxin for treatment of body odour |
| 12/08/2009 | CA2332570C Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 12/08/2009 | CA2218116C Pulmonary delivery of aerosolized medicaments |
| 12/08/2009 | CA2163012C Anti-egfr single-chain fvs and anti-egfr antibodies |
| 12/06/2009 | CA2665955A1 Helicobacter species and cultivation thereof |
| 12/03/2009 | WO2009146392A1 Mechanism of action of primary cell derived biologic |
| 12/03/2009 | WO2009146362A1 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose |
| 12/03/2009 | WO2009146210A2 New human parvovirus: bocavirus |
| 12/03/2009 | WO2009146207A1 Cripto-1 as a biomarker for chronic inflammatory disease |
| 12/03/2009 | WO2009146112A1 Compositions and methods for inhibiting sphingosine kinase |
| 12/03/2009 | WO2009146034A2 Mapk/erk kinase inhibitors and methods of use thereof |
| 12/03/2009 | WO2009146030A1 Methods and systems for reducing inflammation by neuromodulation of t-cell activity |
| 12/03/2009 | WO2009145831A1 Treatment of the idiopathic nephrotic syndrome spectrum diseases using basiliximab |
| 12/03/2009 | WO2009145761A1 Methods and materials for using cells to treat heart tissue |
| 12/03/2009 | WO2009144775A1 Anti-tumor agent |
| 12/03/2009 | WO2009144567A1 High-energy pulsed electric field vaccine adjuvants |
| 12/03/2009 | WO2009144462A2 Laminin receptor binding proteins |
| 12/03/2009 | WO2009144240A1 Composition and method for the assay and treatment of anthrax |
| 12/03/2009 | WO2009144230A1 Protamine/rna nanoparticles for immunostimulation |
| 12/03/2009 | WO2009144088A2 Vaccine for protection against lawsonia intracellulars |
| 12/03/2009 | WO2009143944A2 Treatment of thromboangiitis obliterans by removal of autoantibodies |
| 12/03/2009 | WO2009143935A1 Screening method for agents suitable for prophylaxis and therapy of alzheimer's disease (ad) |
| 12/03/2009 | WO2009143843A1 Indoleamine 2, 3-dioxygenase based immunotherapy |
| 12/03/2009 | WO2009143816A1 Method for isolating cells and disease vectors from bodily fluids |
| 12/03/2009 | WO2009143775A1 Anti-hiv vaccines constructed based on amino acid mutation of attenuated live vaccine of eiav |
| 12/03/2009 | WO2009143584A1 Treatment of pulmonary edema |
| 12/03/2009 | WO2009143565A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 12/03/2009 | WO2009143556A1 TREATMENTS FOR EXCITOTOXICITY AND Aß-MEDIATED TOXICITY AND AGE-ASSOCIATED NEURONAL DYSFUNCTION |
| 12/03/2009 | WO2009118642A3 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
| 12/03/2009 | WO2009114878A3 Methods and compositions for genetic and retinal disease |
| 12/03/2009 | WO2009108633A3 Sphingosine 1-phosphate antagonism |
| 12/03/2009 | WO2009105275A3 Human biomarkers for determining intrinsic b-cell defects |
| 12/03/2009 | WO2009104097A3 Meningococcal fhbp polypeptides |
| 12/03/2009 | WO2009098592A3 Preparation comprising mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating rheumatoid arthritis. |
| 12/03/2009 | WO2009089260A3 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases |
| 12/03/2009 | WO2009048539A3 Use of anti-amyloid beta antibody in ocular diseases |
| 12/03/2009 | WO2009039310A3 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment |
| 12/03/2009 | WO2009027768A3 Immunogenic compositions for gram positive bacteria |
| 12/03/2009 | WO2008093165A3 The use of pgil ohgosaccharyltransferase for o-glycosylating proteins |
| 12/03/2009 | WO2008083680A3 Use of cohn-oncley fractions ii/iii and/or iii for production of a pharmaceutical preparation for treating and preventing organ manifestations in autoimmune diseases |
| 12/03/2009 | WO2004018646A9 Conserved and specific streptococcal genomes |
| 12/03/2009 | US20090300780 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 12/03/2009 | US20090300779 Cancer selective auxotrophs |
| 12/03/2009 | US20090300778 Neutral Sphingomyelinase-E and Its Use |
| 12/03/2009 | US20090299190 Ultrasound Molecular Sensors and Uses Thereof |
| 12/03/2009 | US20090298771 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 12/03/2009 | US20090298099 Gonococcal Proteins and Nucleic Acids |
| 12/03/2009 | US20090298081 Methods of treatment utilizing binding proteins of the interleukin-21 receptor |
| 12/03/2009 | US20090297621 Microparticles For The Treatment Of Disease |
| 12/03/2009 | US20090297620 Anti-Tumor Agent |
| 12/03/2009 | US20090297614 Nanoparticles for providing immune responses against infectious agents |
| 12/03/2009 | US20090297609 Method of Biomolecule Immobilization On Polymers Using Click-Type Chemistry |
| 12/03/2009 | US20090297606 Gamma-lactam compounds for promoting bone growth |
| 12/03/2009 | US20090297598 Therapeutic combination |
| 12/03/2009 | US20090297593 Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment |
| 12/03/2009 | US20090297576 Local Delivery of PAR-1 Antagonists to Treat Vascular Complications |
| 12/03/2009 | US20090297564 Use of a Liquid Allergy Vaccine Formulation for Oromucosal Administration |
| 12/03/2009 | US20090297563 Diagnosis And Treatment of Immune-Related Diseases |
| 12/03/2009 | US20090297562 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 12/03/2009 | US20090297561 Method for vaccination of poultry by bacteriophage lysate bacterin |
| 12/03/2009 | US20090297560 Oral vaccine for Borrelia |
| 12/03/2009 | US20090297559 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents |
| 12/03/2009 | US20090297558 Inactivated Influenza Virus Compositions |